Skip to main content

Chronic Prostatitis/Chronic Pelvic Pain Syndrome

  • Chapter
  • First Online:
Medical Therapy in Urology

Abstract

CP/CPPS is a poorly understood condition that causes significant morbidity. Affecting 5-12% of men worldwide, it is classified, according to the National Institutes of Health (NIH) classification of prostatitis, as Category III (Table 10.1). CP/CPPS is defined as genitourinary pain in the absence of uropathogenic bacteria, detected by standard microbiologic methods [1]. The symptoms are similar to other forms of prostatitis, including lower urinary tract symptoms accompanied by moderate to severe pain in the genitalia, perineum, suprapubic area, and/or lower back lasting for at least 3 months. Patients may also experience diminished sexual health. Overall, CP/CPPS accounts for approximately 90% of prostatitis cases. The diagnosis of CP/CPPS is that of exclusion, and it is important that in the work-up, no reversible cause of the symptoms is missed. The etiology of CP/CPPS is unknown, although many theories exist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3):236-237

    Article  CAS  PubMed  Google Scholar 

  2. True Ld, Berger RE, Rothman I et al (1999) Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 162:2014-2018

    Article  CAS  PubMed  Google Scholar 

  3. Lee JC, Muller CH, Rothman I, et al (2003) Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from those of healthy controls [see comment]. J Urol 169(2):584-587 [discussion: 587-588]

    Google Scholar 

  4. Collins MM, Meigs JB, Barry MJ et al (2002) Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 167:1363-1366

    Article  PubMed  Google Scholar 

  5. Ishigooka M, Zermann DH, Doggweiler R et al (2000) Similarity of distributions of spinal c-Fos and plasma extravasation after acute chemical irritation of the bladder and the prostate. J Urol 164(5):1751-1756

    Article  CAS  PubMed  Google Scholar 

  6. Yang CC, Lee JC, Kromm BG, et al (2003) Pain sensitization in male chronic pelvic pain syndrome: why are symptoms so difficult to treat? J Urol 170(3):823 [discussion: 826-827]

    Google Scholar 

  7. Riley DE, Krieger JN (2002) X Chromosomal short tandem repeat polymorphisms near the phosphoglycerate kinase gene in men with chronic prostatitis. Biochim Biophys Acta 1586(1):99-107

    CAS  PubMed  Google Scholar 

  8. Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5(5):492-518

    CAS  PubMed  Google Scholar 

  9. Nickel JC, Downey J, Clark J et al (2003) Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62(4):614-617

    Article  PubMed  Google Scholar 

  10. Alexander RB, Propert KJ, Schaeffer AJ et al (2004) Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 141(8):581-589

    CAS  PubMed  Google Scholar 

  11. Yang G, Wei Q, Li H et al (2006) The effect of α-adrenergic antagonist in chronic prostatis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials. J Androl 27(6):847-852

    Article  CAS  PubMed  Google Scholar 

  12. Nickel JC, Narayan P, McKay J, Doyle C (2004) Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 171(4):1594-1597

    Article  CAS  PubMed  Google Scholar 

  13. Jeong CW, Lim DJ, Son H, Lee SE, Jeong H (2008) Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination. Urol Int 80(2):157-161

    Article  CAS  PubMed  Google Scholar 

  14. Kaplan SA, Volpe MA, Te AE (2004) A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 171(1):284-288

    Article  PubMed  Google Scholar 

  15. Godfrey RG (1996) A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 156:1047-1052

    Article  CAS  PubMed  Google Scholar 

  16. Dworkin RH, Backonja M, Rowbotham MC et al (2003) Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60:1524-1534

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael A. Pontari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag London

About this chapter

Cite this chapter

Reyes, J.M., Pontari, M.A. (2010). Chronic Prostatitis/Chronic Pelvic Pain Syndrome. In: Shergill, I., Arya, M., Grange, P., Mundy, A. (eds) Medical Therapy in Urology. Springer, London. https://doi.org/10.1007/978-1-84882-704-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-704-2_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-703-5

  • Online ISBN: 978-1-84882-704-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics